Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach

Multiple dysregulated signaling pathways are implicated in the pathogenesis of cancer. The conventional therapies used in cancer prevention/treatment suffer from low efficacy, considerable toxicity, and high cost. Hence, the discovery and development of novel multi-targeted agents to attenuate the d...

Full description

Bibliographic Details
Main Authors: Zeinab Nouri, Sajad Fakhri, Keyvan Nouri, Carly E. Wallace, Mohammad Hosein Farzaei, Anupam Bishayee
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/8/2276
_version_ 1797558152792637440
author Zeinab Nouri
Sajad Fakhri
Keyvan Nouri
Carly E. Wallace
Mohammad Hosein Farzaei
Anupam Bishayee
author_facet Zeinab Nouri
Sajad Fakhri
Keyvan Nouri
Carly E. Wallace
Mohammad Hosein Farzaei
Anupam Bishayee
author_sort Zeinab Nouri
collection DOAJ
description Multiple dysregulated signaling pathways are implicated in the pathogenesis of cancer. The conventional therapies used in cancer prevention/treatment suffer from low efficacy, considerable toxicity, and high cost. Hence, the discovery and development of novel multi-targeted agents to attenuate the dysregulated signaling in cancer is of great importance. In recent decades, phytochemicals from dietary and medicinal plants have been successfully introduced as alternative anticancer agents due to their ability to modulate numerous oncogenic and oncosuppressive signaling pathways. Rutin (also known as rutoside, quercetin-3-<i>O</i>-rutinoside and sophorin) is an active plant-derived flavonoid that is widely distributed in various vegetables, fruits, and medicinal plants, including asparagus, buckwheat, apricots, apples, cherries, grapes, grapefruit, plums, oranges, and tea. Rutin has been shown to target various inflammatory, apoptotic, autophagic, and angiogenic signaling mediators, including nuclear factor-κB, tumor necrosis factor-α, interleukins, light chain 3/Beclin, B cell lymphoma 2 (Bcl-2), Bcl-2 associated X protein, caspases, and vascular endothelial growth factor. A comprehensive and critical analysis of the anticancer potential of rutin and associated molecular targets amongst various cancer types has not been performed previously. Accordingly, the purpose of this review is to present an up-to-date and critical evaluation of multiple cellular and molecular mechanisms through which the anticancer effects of rutin are known to be exerted. The current challenges and limitations as well as future directions of research are also discussed.
first_indexed 2024-03-10T17:27:28Z
format Article
id doaj.art-780dca55172d4b0393e0ee30e6766ba0
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T17:27:28Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-780dca55172d4b0393e0ee30e6766ba02023-11-20T10:08:31ZengMDPI AGCancers2072-66942020-08-01128227610.3390/cancers12082276Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic ApproachZeinab Nouri0Sajad Fakhri1Keyvan Nouri2Carly E. Wallace3Mohammad Hosein Farzaei4Anupam Bishayee5Student Research Committee, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah 6714415153, IranPharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6734667149, IranStudent Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan 8174673461, IranLake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USAPharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6734667149, IranLake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USAMultiple dysregulated signaling pathways are implicated in the pathogenesis of cancer. The conventional therapies used in cancer prevention/treatment suffer from low efficacy, considerable toxicity, and high cost. Hence, the discovery and development of novel multi-targeted agents to attenuate the dysregulated signaling in cancer is of great importance. In recent decades, phytochemicals from dietary and medicinal plants have been successfully introduced as alternative anticancer agents due to their ability to modulate numerous oncogenic and oncosuppressive signaling pathways. Rutin (also known as rutoside, quercetin-3-<i>O</i>-rutinoside and sophorin) is an active plant-derived flavonoid that is widely distributed in various vegetables, fruits, and medicinal plants, including asparagus, buckwheat, apricots, apples, cherries, grapes, grapefruit, plums, oranges, and tea. Rutin has been shown to target various inflammatory, apoptotic, autophagic, and angiogenic signaling mediators, including nuclear factor-κB, tumor necrosis factor-α, interleukins, light chain 3/Beclin, B cell lymphoma 2 (Bcl-2), Bcl-2 associated X protein, caspases, and vascular endothelial growth factor. A comprehensive and critical analysis of the anticancer potential of rutin and associated molecular targets amongst various cancer types has not been performed previously. Accordingly, the purpose of this review is to present an up-to-date and critical evaluation of multiple cellular and molecular mechanisms through which the anticancer effects of rutin are known to be exerted. The current challenges and limitations as well as future directions of research are also discussed.https://www.mdpi.com/2072-6694/12/8/2276rutincancersignaling pathwaystherapeutic targetspharmacologydrug delivery system
spellingShingle Zeinab Nouri
Sajad Fakhri
Keyvan Nouri
Carly E. Wallace
Mohammad Hosein Farzaei
Anupam Bishayee
Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach
Cancers
rutin
cancer
signaling pathways
therapeutic targets
pharmacology
drug delivery system
title Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach
title_full Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach
title_fullStr Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach
title_full_unstemmed Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach
title_short Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach
title_sort targeting multiple signaling pathways in cancer the rutin therapeutic approach
topic rutin
cancer
signaling pathways
therapeutic targets
pharmacology
drug delivery system
url https://www.mdpi.com/2072-6694/12/8/2276
work_keys_str_mv AT zeinabnouri targetingmultiplesignalingpathwaysincancertherutintherapeuticapproach
AT sajadfakhri targetingmultiplesignalingpathwaysincancertherutintherapeuticapproach
AT keyvannouri targetingmultiplesignalingpathwaysincancertherutintherapeuticapproach
AT carlyewallace targetingmultiplesignalingpathwaysincancertherutintherapeuticapproach
AT mohammadhoseinfarzaei targetingmultiplesignalingpathwaysincancertherutintherapeuticapproach
AT anupambishayee targetingmultiplesignalingpathwaysincancertherutintherapeuticapproach